These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 33633826)
1. Mesenchymal stem cell-based treatment in autoimmune liver diseases: underlying roles, advantages and challenges. He C; Yang Y; Zheng K; Chen Y; Liu S; Li Y; Han Q; Zhao RC; Wang L; Zhang F Ther Adv Chronic Dis; 2021; 12():2040622321993442. PubMed ID: 33633826 [TBL] [Abstract][Full Text] [Related]
2. Potential mesenchymal stem cell therapeutics for treating primary biliary cholangitis: advances, challenges, and perspectives. Yang Y; Zhao RC; Zhang F Front Cell Dev Biol; 2022; 10():933565. PubMed ID: 35923849 [TBL] [Abstract][Full Text] [Related]
3. Increase trend in the prevalence and male-to-female ratio of primary biliary cholangitis, autoimmune hepatitis, and primary sclerosing cholangitis in Japan. Tanaka A; Mori M; Matsumoto K; Ohira H; Tazuma S; Takikawa H Hepatol Res; 2019 Aug; 49(8):881-889. PubMed ID: 30932290 [TBL] [Abstract][Full Text] [Related]
4. Challenges and opportunities in achieving effective regulatory T cell therapy in autoimmune liver disease. Richardson N; Wootton GE; Bozward AG; Oo YH Semin Immunopathol; 2022 Jul; 44(4):461-474. PubMed ID: 35641679 [TBL] [Abstract][Full Text] [Related]
5. Single Topic Conference on Autoimmune Liver Disease from the Canadian Association for the Study of the Liver. Montano-Loza AJ; Allegretti JR; Cheung A; Ebadi M; Jones D; Kerkar N; Levy C; Rizvi S; Vierling JM; Alvarez F; Bai W; Gilmour S; Gulamhusein A; Guttman O; Hansen BE; MacParland S; Mason A; Onofrio F; Santamaria P; Stueck A; Swain M; Vincent C; Ricciuto A; Hirschfield G Can Liver J; 2021; 4(4):401-425. PubMed ID: 35989897 [TBL] [Abstract][Full Text] [Related]
6. National incidence of autoimmune liver diseases and its relationship with the human development index. Pan HY; Dai YN; Zheng JN; Shi KQ; Van Poucke S; Zou H; Zheng MH Oncotarget; 2016 Jul; 7(29):46273-46282. PubMed ID: 27323833 [TBL] [Abstract][Full Text] [Related]
7. MicroRNAs in autoimmune liver diseases: from diagnosis to potential therapeutic targets. Huang C; Xing X; Xiang X; Fan X; Men R; Ye T; Yang L Biomed Pharmacother; 2020 Oct; 130():110558. PubMed ID: 32781357 [TBL] [Abstract][Full Text] [Related]
8. Pathological features of biopsy in autoimmune liver disease: a report of 109 cases. Yao Y; Xu Z; Wan Y; Cheng Y; Li Y; Zhu X Int J Clin Exp Pathol; 2017; 10(8):8974-8979. PubMed ID: 31966767 [TBL] [Abstract][Full Text] [Related]
9. Cirrhosis and autoimmune liver disease: Current understanding. Liberal R; Grant CR World J Hepatol; 2016 Oct; 8(28):1157-1168. PubMed ID: 27729952 [TBL] [Abstract][Full Text] [Related]
11. Autoimmune liver disease, autoimmunity and liver transplantation. Carbone M; Neuberger JM J Hepatol; 2014 Jan; 60(1):210-23. PubMed ID: 24084655 [TBL] [Abstract][Full Text] [Related]
12. Epstein-barr virus as a trigger of autoimmune liver diseases. Rigopoulou EI; Smyk DS; Matthews CE; Billinis C; Burroughs AK; Lenzi M; Bogdanos DP Adv Virol; 2012; 2012():987471. PubMed ID: 22693505 [TBL] [Abstract][Full Text] [Related]
13. Antibodies against multiple post-translationally modified proteins aid in diagnosis of autoimmune hepatitis and associate with complete biochemical response to treatment. van den Beukel MD; Stoelinga AEC; van der Meer AJ; van der Meulen S; Zhang L; Tushuizen ME; van Hoek B; Trouw LA Front Med (Lausanne); 2023; 10():1195747. PubMed ID: 37564051 [TBL] [Abstract][Full Text] [Related]
14. Mesenchymal Stem Cells as New Therapeutic Agents for the Treatment of Primary Biliary Cholangitis. Arsenijevic A; Harrell CR; Fellabaum C; Volarevic V Anal Cell Pathol (Amst); 2017; 2017():7492836. PubMed ID: 29410945 [TBL] [Abstract][Full Text] [Related]
15. De novo and recurrent liver disease. Ip S; Bhanji RA; Ebadi M; Mason AL; Montano-Loza AJ Best Pract Res Clin Gastroenterol; 2020; 46-47():101688. PubMed ID: 33158472 [TBL] [Abstract][Full Text] [Related]
16. Relationship between autoimmune liver disease and autoimmune thyroid disease: a cross-sectional study. Zeng Q; Zhao L; Wang C; Gao M; Han X; Chen C; Tu C; Han P; Li J Scand J Gastroenterol; 2020 Feb; 55(2):216-221. PubMed ID: 32083943 [No Abstract] [Full Text] [Related]
17. Autoimmune liver diseases and antiphospholipid antibodies positivity: a meta-analysis of literature studies. Ambrosino P; Lupoli R; Spadarella G; Tarantino P; Di Minno A; Tarantino L; Di Minno MN J Gastrointestin Liver Dis; 2015 Mar; 24(1):25-34, 3 p following 34. PubMed ID: 25822431 [TBL] [Abstract][Full Text] [Related]
18. [Clinical analysis of liver transplantation in end-stage autoimmune liver diseases]. Gu J; Jiang W; Li J; Zhang N; Zhang L; Wang H; Lu W Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Nov; 31(11):1401-1405. PubMed ID: 31898573 [TBL] [Abstract][Full Text] [Related]